Skip to main content
. Author manuscript; available in PMC: 2009 Aug 15.
Published in final edited form as: J Immunol. 2008 Aug 15;181(4):2563–2571. doi: 10.4049/jimmunol.181.4.2563

FIGURE 2. TRAMP mice are tolerant towards the tumor-associated SV40IV epitope.

FIGURE 2

A-B, TRAMP mice and as a control non-transgenic littermates received an intranasal flu-T infection. 10 days post infection, spleen cells were isolated and cultured in the presence of either SV40404-411 or (as a control) the influenza A nucleoprotein derived PR366-374 epitope (5×10-4 μg/ml) for 14 days. Antigen specific T cells were measured by intracellular IFNγ staining after incubation with 100 ng/ml of the relevant peptide. Shown are dot-plots of 2 representative cultures (A) and cumulative data of all cultures (B). Numbers in upper right corner of dot-plots refer to percentage of IFNγ+ CD8+ cells of total CD8+ cells. Circles in graphs represent individual mice, bars indicate averages.